Form 4: Director John Coghlan Sells Life360 Shares

Director John Coghlan reported a series of transactions involving the sale of Life360, Inc. common stock, executed under a Rule 10b5-1 trading plan.

Summary

• Director John Coghlan has reported the sale of Life360, Inc. common stock.
• These sales were conducted under a pre-arranged Rule 10b5-1 trading plan, adopted on December 8, 2025.
• The plan ensures sales are based on a predetermined formula established when the reporting person was not aware of material nonpublic information.
• Transactions occurred on July 1, 2026, with weighted average prices reported for different tranches of sales.
• Details on specific prices within the reported ranges will be provided upon request.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions under a pre-established compliant plan, without indicating significant positive or negative developments for the company.

Negatives

• Director John Coghlan sold a total of 3,798 shares of common stock at a weighted average price of $56.04.
• An additional 202 shares were sold at a weighted average price of $56.57.
• The total number of shares beneficially owned after these transactions is 55,494, which includes restricted stock units.

Risks

• The sales were executed under a Rule 10b5-1 plan, which is designed to provide an affirmative defense against insider trading allegations, but the existence of such plans can sometimes be perceived negatively by the market if not clearly communicated.
• The reporting person is selling shares, which could be interpreted as a lack of confidence in future price appreciation, although the Rule 10b5-1 plan mitigates this interpretation.

Future Outlook

The filing does not contain forward-looking statements or guidance. It reports on past transactions.

Management Comments

• The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
• The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions. The use of a Rule 10b5-1 plan by a director of a technology company like Life360 is a common practice to manage personal stock sales in a compliant manner, especially given the potential for access to material non-public information.

Stakeholder Impact

• Shareholders: The sale of shares by a director may be observed, but the Rule 10b5-1 plan mitigates concerns about insider trading. The market impact is likely to be minimal given the nature of the filing.
• Management: Reinforces the company's adherence to regulatory requirements for insider transactions.
• Employees: The transactions do not directly impact employee stock options or grants but are part of the broader corporate financial disclosures.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Rule 10b5-1, Life360, LIF, Stock Sale, Director Transaction, Beneficial Ownership, Securities Exchange Act